Page last updated: 2024-11-02

pioglitazone and Congenital Myotonic Dystrophy

pioglitazone has been researched along with Congenital Myotonic Dystrophy in 3 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research Excerpts

ExcerptRelevanceReference
" However, the effects of pioglitazone in overweight patients with myotonic dystrophy and type 2 diabetes mellitus have not been established."7.75Dramatic improvement of blood glucose control after pioglitazone treatment in poorly controlled over-weight diabetic patients with myotonic dystrophy. ( Abe, H; Funayama, T; Hirose, T; Ikeda, F; Kaga, H; Kanazawa, A; Kawamori, R; Kudo, K; Mita, T; Tokoro, M; Watada, H, 2009)
"We report beneficial effects of pioglitazone on insulin resistance in diabetes mellitus accompanied with myotonic dystrophy (DM1)."7.73[Long-term treatment of diabetes mellitus in myotonic dystrophy with pioglitazone]. ( Isobe, T; Kawai, M; Ogata, K; Ogawa, M; Oya, Y; Shirafuji, T; Yamamoto, T, 2005)
"Pioglitazone was effective in improving hyperinsulinemia and reactive hypoglycemia in nondiabetic DM1."5.35[Successful treatment of recurrent hypoglycemia by pioglitazone in a patient with myotonic dystrophy]. ( Furusawa, Y; Murata, M; Nonaka, I; Oya, Y; Yamamoto, T, 2009)
" However, the effects of pioglitazone in overweight patients with myotonic dystrophy and type 2 diabetes mellitus have not been established."3.75Dramatic improvement of blood glucose control after pioglitazone treatment in poorly controlled over-weight diabetic patients with myotonic dystrophy. ( Abe, H; Funayama, T; Hirose, T; Ikeda, F; Kaga, H; Kanazawa, A; Kawamori, R; Kudo, K; Mita, T; Tokoro, M; Watada, H, 2009)
"We report beneficial effects of pioglitazone on insulin resistance in diabetes mellitus accompanied with myotonic dystrophy (DM1)."3.73[Long-term treatment of diabetes mellitus in myotonic dystrophy with pioglitazone]. ( Isobe, T; Kawai, M; Ogata, K; Ogawa, M; Oya, Y; Shirafuji, T; Yamamoto, T, 2005)
"Pioglitazone was effective in improving hyperinsulinemia and reactive hypoglycemia in nondiabetic DM1."1.35[Successful treatment of recurrent hypoglycemia by pioglitazone in a patient with myotonic dystrophy]. ( Furusawa, Y; Murata, M; Nonaka, I; Oya, Y; Yamamoto, T, 2009)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, H1
Mita, T1
Kudo, K1
Funayama, T1
Tokoro, M1
Kaga, H1
Ikeda, F1
Kanazawa, A1
Hirose, T1
Kawamori, R1
Watada, H1
Yamamoto, T2
Oya, Y2
Furusawa, Y1
Nonaka, I1
Murata, M1
Isobe, T1
Shirafuji, T1
Ogata, K1
Ogawa, M1
Kawai, M1

Other Studies

3 other studies available for pioglitazone and Congenital Myotonic Dystrophy

ArticleYear
Dramatic improvement of blood glucose control after pioglitazone treatment in poorly controlled over-weight diabetic patients with myotonic dystrophy.
    Endocrine journal, 2009, Volume: 56, Issue:7

    Topics: Blood Glucose; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Myotonic Dystrophy; O

2009
[Successful treatment of recurrent hypoglycemia by pioglitazone in a patient with myotonic dystrophy].
    Rinsho shinkeigaku = Clinical neurology, 2009, Volume: 49, Issue:10

    Topics: Adult; Female; Humans; Hypoglycemia; Hypoglycemic Agents; Myotonic Dystrophy; Pioglitazone; Thiazoli

2009
[Long-term treatment of diabetes mellitus in myotonic dystrophy with pioglitazone].
    Rinsho shinkeigaku = Clinical neurology, 2005, Volume: 45, Issue:4

    Topics: Adult; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Mid

2005